Microvascular dysfunction in insulin resistance

Microcirculation and Insulin Resistance

Volumn , Issue , 2009, Pages 31-40

  Frisbee, Jefferson C ^a   Brock, Robert W ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Impaired glycemic control; Skeletal muscle perfusion; Vascular reactivity; Vasculopathy

Indexed keywords

EID: 84860497803     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.2174/978160805057410901010031     Document Type: Chapter

References (84)

1. American Diabetes Association. All About Insulin Resistance, Toolkit No. 5. American Diabetes Association Type II Diabetes Information: 2004.
2. American Heart Association. Insulin Resistance. American Heart Association Diseases and Conditions: 2004.
3. Perez-Martin A, Raynaud E, and Mercier J. Insulin resistance and associated metabolic abnormalities in muscle: effects of exercise. Obes.Rev. 2: 47-59, 2001.
4. Clausen JO, Hansen T, Bjorbaek C, Echwald SM, Urhammer SA, Rasmussen S, Andersen CB, Hansen L, Almind K, Winther K, and. Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1. Lancet 346: 397-402, 1995.
5. Zouali H, Velho G, and Froguel P. Polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N.Engl.J.Med. 328: 1568, 1993.
6. Olivier M, Hsiung CA, Chuang LM, Ho LT, Ting CT, Bustos VI, Lee TM, De Witte A, Chen YD, Olshen R, Rodriguez B, Wen CC, and Cox DR. Single nucleotide polymorphisms in protein tyrosine phosphatase 1{beta} (PTPN1) are associated with essential hypertension and obesity. Hum.Mol.Genet. 13: 1885-1892, 2004.
7. Nandi A, Kitamura Y, Kahn CR, and Accili D. Mouse models of insulin resistance. Physiol Rev. 84: 623-647, 2004.
8. Brindley DN, Russell JC. Animal models of insulin resistance and cardiovascular disease: some therapeutic approaches using JCR: LA-cp rat. Diabetes Obes. Metab 4: 1-10, 2002.
9. Mathe D. Dyslipidemia and diabetes: animal models. Diabete Metab 21: 106-111, 1995.
10. Katakam PV, Ujhelyi MR, Hoenig ME, and Miller AW. Endothelial dysfunction precedes hypertension in diet-induced insulin resistance. Am.J. Physiol 275: R788-R792, 1998.
11. Ribeiro MM, Silva AG, Santos NS, Guazzelle I, Matos LNJ, Trombetta IC, Halpern A, Negrao CE, Villares SMF. (2005). Diet and exercise training restore blood pressure and vasodilatory responses during physiological maneuvers in obese children. Circulation 111: 19151923.
12. Negrao CE, Trombetta IC, Batalha LT, Ribeiro MM, Rondon MUPB, Tinucci T, Forjaz CLM, Barretto ACP, Halpern A, Villares SMF. (2001). Muscle metaboreflex control is diminished in normotensive obese women. Am J Physiol Heart Circ Physiol 281: H469-H475.
13. Menon RK, Grace AA, Burgoyne W, Fonseca VA, James IM, Dandona P. (1992). Muscle blood flow in diabetes mellitus. Evidence of abnormality after exercise. Diabetes Care 15: 693-695.
14. Young JL, Pendergast DR, Steinbach J. (1991). Oxygen transport and peripheral microcirculation in longterm diabetes. Proc Soc Exp Biol Med 196: 61-68.
15. Frisbee JC. (2003). Impaired skeletal muscle perfusion in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 285: R1124-R1134.
16. Xiang L, Naik JS, Hodnett BL, Hester RL. (2006). Altered arachidonic acid metabolism impairs functional vasodilation in metabolic syndrome. Am J Physiol Regul Integr Comp Physiol 290: R134-R138.
17. Frisbee JC. Impaired dilation of skeletal muscle microvessels to reduced oxygen tension in diabetic obese Zucker rats. Am.J. Physiol Heart Circ. Physiol 281: H1568-H1574, 2001.
18. Laight DW, Desai KM, Anggard EE, and Carrier MJ. Endothelial dysfunction accompanies a pro-oxidant, pro-diabetic challenge in the insulin resistant, obese Zucker rat in vivo. Eur.J.Pharmacol. 402: 95-99, 2000.
19. Erdos B, Snipes JA, Miller AW, and Busija DW. Cerebrovascular dysfunction in Zucker obese rats is mediated by oxidative stress and protein kinase C. Diabetes 53: 1352-1359, 2004.
20. Hayashi K, Kanda T, Homma K, Tokuyama H, Okubo K, Takamatsu I, Tatematsu S, Kumagai H, and Saruta T. Altered renal microvascular response in Zucker obese rats. Metabolism 51: 1553-1561, 2002.
21. Wu X, Makynen H, Kahonen M, Arvola P, and Porsti I. Mesenteric arterial function in vitro in three models of experimental hypertension. J.Hypertens. 14: 365-372, 1996.
22. Miller AW, Katakam PV, and Ujhelyi MR. Impaired endothelium-mediated relaxation in coronary arteries from insulin-resistant rats. J.Vasc.Res. 36: 385-392, 1999.
23. Katakam PV, Ujhelyi MR, and Miller AW. EDHF-mediated relaxation is impaired in fructose-fed rats. J.Cardiovasc.Pharmacol. 34: 461-467, 1999.
24. Erdos B, Miller AW, and Busija DW. Impaired endothelium-mediated relaxation in isolated cerebral arteries from insulin-resistant rats. Am.J. Physiol Heart Circ. Physiol 282: H2060-H2065, 2002.
25. Miller AW, Dimitropoulou C, Han G, White RE, Busija DW, and Carrier GO. Epoxyeicosatrienoic acidinduced relaxation is impaired in insulin resistance. Am.J. Physiol Heart Circ. Physiol 281: H1524-H1531, 2001.
26. Dimitropoulou C, Han G, Miller AW, Molero M, Fuchs LC, White RE, and Carrier GO. Potassium (BKCa) currents are reduced in microvascular smooth muscle cells from insulin-resistant rats. Am.J. Physiol Heart Circ. Physiol 282: H908-H917, 2002.
27. Frisbee JC, Maier KG, and Stepp DW. Oxidant stress-induced increase in myogenic activation of skeletal muscle resistance arteries in obese Zucker rats. Am.J. Physiol Heart Circ. Physiol 283: H2160-H2168, 2002.
28. Frisbee JC, Stepp DW. Impaired NO-dependent dilation of skeletal muscle arterioles in hypertensive diabetic obese Zucker rats. Am J Physiol Heart Circ Physiol. 281: H1304-H1311, 2001.
29. Xiang L, Naik J, Hester RL. Exercise-induced increase in skeletal muscle vasodilatory responses in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol. 288: R987-R991, 2005.
30. Johnson FK, Johnson RA, Durante W, Jackson KE, Stevenson BK, Peyton KJ. Metabolic syndrome increases endogenous carbon monoxide production to promote hypertension and endothelial dysfunction in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol. 290: R601-R608, 2006.
31. Fulton D, Harris MB, Kemp BE, Venema RC, Marrero MB, Stepp DW. Insulin resistance does not diminish eNOS expression, phosphorylation, or binding to HSP-90. Am J Physiol Heart Circ Physiol. 287: H2384-H2393, 2004.
32. Geakelman O, Brodsky SV, Zhang F, Chander PN, Friedli C, Nasjletti A, Goligorsky MS. Endothelial dysfunction as a modifier of angiogenic response in Zucker diabetic fat rat: amelioration with Ebselen. Kidney Int. 66: 2337-2347, 2004.
33. Brzezinska AK, Gebremedhin D, Chilian WM, Kalyanaraman B, Elliott SJ. Peroxynitrite reversibly inhibits Ca(2+)-activated K(+) channels in rat cerebral artery smooth muscle cells. Am J Physiol Heart Circ Physiol. 278: H1883-H1890, 2000.
34. Bohlen HG. Protein kinase betaII in Zucker obese rats compromises oxygen and flow-mediated regulation of nitric oxide formation. Am J Physiol Heart Circ Physiol. 286: H492-H497, 2004.
35. Erdos B, Simandle SA, Snipes JA, Miller AW, and Busija DW. Potassium channel dysfunction in cerebral arteries of insulin-resistant rats is mediated by reactive oxygen species. Stroke 35: 964-969, 2004.
36. Janiak P, Lainee P, Grataloup Y, Luyt CE, Bidouard JP, Michel JB, O'Connor SE, Herbert JM. Serotonin receptor blockade improves distal perfusion after lower limb ischemia in the fatty Zucker rat. Cardiovasc Res. 56: 293-302, 2002.
37. Wu SQ, Hopfner RL, McNeill JR, Wilson TW, Gopalakrishnan V. Altered paracrine effect of endothelin in blood vessels of the hyperinsulinemic, insulin resistant obese Zucker rat. Cardiovasc Res. 45: 994-1000, 2000.
38. van Baak MA. The peripheral sympathetic nervous system in human obesity. Obes Rev. 2: 3-14, 2001.
39. Carlson SH, Shelton J, White CR, Wyss JM. Elevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic obese Zucker rats. Hypertension. 35: 403-408, 2000.
40. Stepp DW, Frisbee JC. Augmented adrenergic vasoconstriction in hypertensive diabetic obese Zucker rats. Am J Physiol Heart Circ Physiol. 282: H816-H820, 2002.
41. Schreihofer AM, Hair CD, Stepp DW. Reduced plasma volume and mesenteric vascular reactivity in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol. 288: R253-R261, 2005.
42. Naik JS, Xiang L, Hester RL. Enhanced role for RhoA-associated kinase in adrenergic-mediated vasoconstriction in gracilis arteries from obese Zucker rats. Am J Physiol Regul Integr Comp Physiol. 290: R154-R161, 2006.
43. Frisbee JC. Enhanced arteriolar alpha-adrenergic constriction impairs dilator responses and skeletal muscle perfusion in obese Zucker rats. J Appl Physiol. 97: 764-772, 2004.
44. Laakso, M., Edelman, S., Brechtel, G., Baron, A. (1990). Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. J Clin Invest 85: 1844-1852.
45. Baron, A., Laakso, M., Brechtel, G., Edelman, S. (1991). Reduced capacity and affinity of skeletal muscle for insulin- mediated glucose uptake in noninsulin-dependent diabetic subjects. J Clin Invest 87: 1186-1194.
46. Baron, A. (1994). Hemodynamic actions of insulin. Am J Physiol 267: E187-E202.
47. Clark, M., Wallis, M., Barrett, E., Vincent, M., Richards, S., Clerk, L., Rattigan, S. (2003). Blood flow and muscle metabolism: a focus on insulin action. Am J Physiol Endocrinol Metab 284: E241-E258.
48. Coggins, M., Lindner, J., Rattigan, S., Jahn, L., Fasy, E., Kaul, S., Barrett, E. (2001). Physiologic hyperinsulinemia enhances human skeletal muscle perfusion by capillary recruitment. Diabetes 50: 2682-2690.
49. Rattigan, S., Clark, M., Barrett, E. (1999). Acute vasoconstriction-induced insulin resistance in rat muscle in vivo. Diabetes 48: 564-569.
50. Vincent, M., Dawson, D., Clark, A., Lindner, J., Rattigan, S., Clark, M., Barrett, E. (2002). Skeletal muscle microvascular recruitment by physiological hyperinsulinemia precedes increases in total blood flow. Diabetes 51: 42-48.
51. Vincent, M., Clerk, L., Lindner, J., Klibanov, A., Clark, M., Rattigan, S., Barrett, E. (2004). Microvascular recruitment is an early insulin effect that regulates skeletal muscle glucose uptake in vivo. Diabetes 53: 1418-1423.
52. Zhang, L., Vincent, M., Richards, S., Clerk, L., Rattigan, S., Clark, M., Barrett, E. (2004). Insulin sensitivity of muscle capillary recruitment in vivo. Diabetes 53: 447-453.
53. Bradley, E., Clark, M., Rattigan, S. (2006). Acute effects of wortmannin on insulin's hemodynamic and metabolic actions in vivo. Am J Physiol Endocrinol Metab In press.
54. Vincent, M., Barrett, E., Lindner, J., Clark, M., Rattigan, S. (2003). Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin. Am J Physiol Endocrinol Metab 285: E123-E129.
55. Rattigan, S., Zhang, L., Mahajan, H., Kolka, C., Richards, S., Clark, M. (2006). Factors influencing the hemodynamic and metabolic effects of insulin in muscle. Curr Diab Rev 2: 61-70.
56. LeBrasseur, N., Ruderman, N. (2005). Why might thiazolidinediones increase exercise capacity in patients with type 2 diabetes? Diabetes Care 28: 2975-2977.
57. Frisbee JC. Remodeling of the skeletal muscle microcirculation increases resistance to perfusion in obese Zucker rats. Am J Physiol Heart Circ Physiol. 2003; 285: H104-11.
58. Gavin TP, Stallings HW 3rd, Zwetsloot KA, Westerkamp LM, Ryan NA, Moore RA, Pofahl WE, Hickner RC. Lower capillary density but no difference in VEGF expression in obese vs. lean young skeletal muscle in humans. J Appl Physiol. 2005; 98: 315-21.
59. Green DJ, Maiorana A, O'Driscoll G, Taylor R. Effect of exercise training on endothelium-derived nitric oxide function in humans. J Physiol. 2004; 561: 1-25.
60. Stainsby WN, Snyder B, Welch HG. A pictographic essay on blood and tissue oxygen transport. Med Sci Sports Exerc. 1988; 20: 213-21.
61. Greene AS, Tonellato PJ, Zhang Z, Lombard JH, Cowley AW Jr. Effect of microvascular rarefaction on tissue oxygen delivery in hypertension. Am J Physiol. 1992; 262: H1486-93.
62. Sharma AM, Chetty VT. Obesity, hypertension and insulin resistance. Acta Diabetol. 2005; 42 Suppl 1: S3-8.
63. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation. 2005; 111: 1448-54.
64. Frisbee JC. Hypertension-independent microvascular rarefaction in the obese Zucker rat model of the metabolic syndrome. Microcirculation. 2005; 12: 383-92.
65. Toblli JE, Cao G, DeRosa G, Di Gennaro F, Forcada P. Angiotensin-converting enzyme inhibition and angiogenesis in myocardium of obese Zucker rats. Am J Hypertens. 2004; 17: 172-80.
66. Toblli JE, DeRosa G, Rivas C, Cao G, Piorno P, Pagano P, Forcada P. Cardiovascular protective role of a low-dose antihypertensive combination in obese Zucker rats. J Hypertens. 2003; 21: 611-20.
67. Frisbee JC. Reduced nitric oxide bioavailability contributes to skeletal muscle microvessel rarefaction in the metabolic syndrome. Am J Physiol Regul Integr Comp Physiol. 2005; 289: R307-R316.
68. He Z, Opland DM, Way KJ, Ueki K, Bodyak N, Kang PM, Izumo S, Kulkarni RN, Wang B, Liao R, Kahn CR, King GL. Regulation of vascular endothelial growth factor expression and vascularization in the myocardium by insulin receptor and PI3K/Akt pathways in insulin resistance and ischemia. Arterioscler Thromb Vasc Biol. 2006; 26: 787-93.
69. Green DJ, Maiorana A, O'Driscoll G, Taylor R. Effect of exercise training on endothelium-derived nitric oxide function in humans. J Physiol. 2004; 561: 1-25.
70. Maiorana A, O'Driscoll G, Taylor R, Green D. Exercise and the nitric oxide vasodilator system. Sports Med. 2003; 33: 1013-35.
71. Ivy JL. Role of exercise training in the prevention and treatment of insulin resistance and non-insulindependent diabetes mellitus. Sports Med. 1997; 24: 321-36.
72. Krotkiewski M, Bylund-Fallenius AC, Holm J, Bjorntorp P, Grimby G, Mandroukas K. Relationship between muscle morphology and metabolism in obese women: the effects of long-term physical training. Eur J Clin Invest. 1983; 13: 5-12.
73. Krotkiewski M. Physical training in the prophylaxis and treatment of obesity, hypertension and diabetes. Scand J Rehabil Med Suppl. 1983; 9: 55-70.
74. Lash JM, Sherman WM, Hamlin RL. Capillary basement membrane thickness and capillary density in sedentary and trained obese Zucker rats. Diabetes. 1989; 38: 854-60.
75. Benoit H, Jordan M, Wagner H, Wagner PD. Effect of NO, vasodilator prostaglandins, and adenosine on skeletal muscle angiogenic growth factor gene expression. J Appl Physiol. 1999; 86: 1513-8.
76. Buckwalter JB, Curtis VC, Valic Z, Ruble SB, Clifford PS. Endogenous vascular remodeling in ischemic skeletal muscle: a role for nitric oxide. J Appl Physiol. 2003; 94: 935-40.
77. Laufs U, Werner N, Link A, Endres M, Wassmann S, Jurgens K, Miche E, Bohm M, Nickenig G. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation. 2004; 109: 220-6.
78. Lloyd PG, Prior BM, Yang HT, Terjung RL. Angiogenic growth factor expression in rat skeletal muscle in response to exercise training. Am J Physiol Heart Circ Physiol. 2003; 284: H1668-78.
79. Lloyd PG, Prior BM, Li H, Yang HT, Terjung RL. VEGF receptor antagonism blocks arteriogenesis, but only partially inhibits angiogenesis, in skeletal muscle of exercise-trained rats. Am J Physiol Heart Circ Physiol. 2005; 288: H759-68.
80. Suzuki J. L-arginine supplementation causes additional effects on exercise-induced angiogenesis and VEGF expression in the heart and hind-leg muscles of middle-aged rats. J Physiol Sci. 2006; 56: 39-44.
81. Lithell H, Krotkiewski M, Kiens B, Wroblewski Z, Holm G, Stromblad G, Grimby G, Bjorntorp P. Nonresponse of muscle capillary density and lipoprotein-lipase activity to regular training in diabetic patients. Diabetes Res. 1985; 2: 17-21.
82. Frisbee JC, Samora JB, Peterson J, Bryner R. Exercise training blunts microvascular rarefaction in the metabolic syndrome. Am J Physiol Heart Circ Physiol. 2006; 291: H2483-92.
83. Torgan CE, Brozinick JT Jr, Kastello GM, Ivy JL. Muscle morphological and biochemical adaptations to training in obese Zucker rats. J Appl Physiol. 1989; 67: 1807-13.
84. Kern PA, Simsolo RB, Fournier M. Effect of weight loss on muscle fiber type, fiber size, capillarity, and succinate dehydrogenase activity in humans. J Clin Endocrinol Metab. 1999; 84: 4185-90.